Multicentre, double-blind, placebo controlled randomised clinical study of URO-VAXOM in female patients suffering from uncomplicated recurrent urinary tract infections.

Trial Profile

Multicentre, double-blind, placebo controlled randomised clinical study of URO-VAXOM in female patients suffering from uncomplicated recurrent urinary tract infections.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Escherichia-coli-strains (Primary) ; Nitrofurantoin
  • Indications Bacterial infections; Urinary tract infections
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors OM Pharma
  • Most Recent Events

    • 09 Feb 2013 Planned number of patients changed from 432 to 446 as reported by European Clinical Trials Database.
    • 16 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top